It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2018.
2018 | Hyderabad, Telangana, India | ActiveDr.Netra Pharmaceuticals Private Limited, a active private limited company, was established on 18 September 2018 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the hospital and medical care sector, it holds CIN: U24100TG2018PTC126749. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Sreenivasa Kanishk Pallapu (Director), Nikhil Sampangi (Director), Sreenivasa Rao Pallapu (Director). Past directors included Sreenivasa Kanishk Pallapu, Nikhil Sampangi, Nirmala Pallapu. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No.2-45/2, Sharif Nagar, Kothapet, Hyderabad, Telangana, 500060.
U24100TG2018PTC126749
126749
18 September 2018
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Dr.Netra Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sreenivasa Kanishk Pallapu | Director | 11 Dec 2023 | Current |
| Nikhil Sampangi | Director | 27 Sep 2022 | Current |
| Sreenivasa Rao Pallapu | Director | 18 Sep 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 11 Dec 2023 | Past |
| Pramod Abcsdd | Director Appointed In Casual Vacancy | 27 Sep 2022 | Past |
| Pramod Abcsdd | Director | 27 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dr.Netra Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 0.14% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.95%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
Unlock access to Dr.Netra Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Dr.Netra Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Dr.Netra Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr.Netra Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Dr.Netra Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Dr.Netra Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
The activity Sreenivasa Kanishk Pallapu was appointed as a Director was appointed as a Director on 11 Dec 2023 & has been associated with this company since 2 years 1 month . was completed.
The activity Nikhil Sampangi was appointed as a Director was appointed as a Director on 27 Sep 2022 & has been associated with this company since 3 years 3 months . was completed.
Progress on Sreenivasa Rao Pallapu was appointed as a Director was appointed as a Director on 18 Sep 2018 & has been associated with this company since 7 years 3 months . was documented.
The activity Dr.Netra Pharmaceuticals Private Limited was registered on 18 Sep 2018 with Roc Hyderabad & aged 7 years 3 months as per MCA records. was completed.
The CIN of Dr.Netra Pharmaceuticals Private Limited is U24100TG2018PTC126749.
Dr.Netra Pharmaceuticals Private Limited is headquartered at H.No.2-45/2, Sharif Nagar, Kothapet, Hyderabad, Telangana, 500060.
Dr.Netra Pharmaceuticals Private Limited was incorporated on 18 September 2018.
The current directors of Dr.Netra Pharmaceuticals Private Limited are
The primary industry of Dr.Netra Pharmaceuticals Private Limited is Hospital And Medical Care.
Dr.Netra Pharmaceuticals Private Limited is unlisted.
The authorized capital of Dr.Netra Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX